Tag: tumor marker test

Hospitals Recognize Need for Uniform Lab Test Data

By Joseph Burns, from the Volume XX No. 12 - September 9, 2013 issue

CEO SUMMARY: Hospitals may soon insist that payers allow their in-house labs to provide outpatient testing regardless of exclusive managed care contracts with national lab companies. The migration to accountable care organizations (ACOs) and medical homes makes it essential that physicians have access to lab data across the entire continuum of care. Standardization of reporting

View Article

Bio-Reference Enters DNA Sequencing Market

By Robert Michel, from the Volume XIII No. 12 - September 5, 2006 issue

CEOSUMMARY: Bio-Reference Laboratories has just placed an unexpected bet on the wide-open opportunities in genetic testing. The acquisition of GeneDX brings it a respected team of geneticists, capabilities in full DNA sequencing, and a proven track record in testing for rare and complex hereditary diseases. It also opens a new lab testing market niche for

View Article

Volume XXVI No. 5 – April 8, 2019

IT'S A FIRST FOR THE CLINICAL LAB INDUSTRY - and American industry as a whole. This issue exclusively reveals that after two years of testing, a lab has achieved the first revenue-generating flight of an unmanned drone in the U.S. Now, the lab's transport of supplies and specimens can safely bypass traffic regularly. Remarkably, the project has involved the cooperation of UPS and both the FAA and state regulators. Also, TDR reports that another government initiative, the National Correct Coding Initiative, has apparently gone awry. Labs could be harmed if they submit claims incorrectly based on the NCCI.

See the full table of contents

Tag: tumor marker test

Enter Your Login Credentials